Table 2. Statin prescriptions in hypercholesterolemic subjects within the first 6 months after the NHSP.
| All ages | Age 20-39 yr | Age 40-59 yr | Age ≥60 yr | |||||
|---|---|---|---|---|---|---|---|---|
| Male | Female | Male | Female | Male | Female | Male | Female | |
| After newly diagnosed hypercholesterolemia | ||||||||
| Total | n=60,093 | n=53,992 | n=20,328 | n=5,490 | n=30,492 | n=30,285 | n=9,273 | n=18,217 |
| No (%) treated | 3,739 (6.2) | 6,103 (11.30) | 486 (2.4) | 90 (1.6) | 2,230 (7.3) | 3,735 (12.3) | 1,023 (11.0) | 2,278 (12.5) |
| With hypertension* | n=18,535 | n=14,598 | n=4,843 | n=342 | n=9,663 | n=6,759 | n=4,029 | n=7,497 |
| No (%) treated | 1,352 (7.3) | 1,880 (12.9) | 156 (3.2) | 13 (3.8) | 789 (8.2) | 947 (14.0) | 407 (10.1) | 920 (12.3) |
| With diabetes* | n=6,151 | n=4,541 | n=1,063 | n=165 | n=3,593 | n=2,044 | n=1,495 | n=2,332 |
| No (%) treated | 628 (10.2) | 711 (15.7) | 52 (4.9) | 8 (4.9) | 381 (10.6) | 375 (18.4) | 195 (13.0) | 328 (14.1) |
| After sustained hypercholesterolemia in the next screening by NHSP | ||||||||
| Total | n=11,950 | n=8,835 | n=4,192 | n=592 | n=6,144 | n=4,860 | n=1,614 | n=3,383 |
| No (%) treated | 1,016 (8.5) | 1,513 (17.1) | 180 (4.3) | 36 (6.1) | 580 (9.4) | 883 (18.2) | 256 (15.9) | 594 (17.6) |
| With hypertension* | n=3,196 | n=2,121 | n=923 | n=34 | n=1,637 | n=934 | n=636 | n=1,153 |
| No (%) treated | 327 (10.2) | 421 (19.9) | 53 (5.7) | 4 (11.8) | 177 (10.8) | 205 (22.0) | 97 (15.3) | 212 (18.4) |
| With diabetes* | n=1,216 | n=759 | n=272 | n=20 | n=680 | n=342 | n=264 | n=397 |
| No (%) treated | 145 (11.9) | 171 (22.5) | 24 (8.8) | 2 (10.0) | 80 (11.8) | 88 (25.7) | 41 (15.5) | 81 (20.4) |
*Diagnosed with hypertension (ICD-10 codes I10-I15) or diabetes (ICD-10 codes E10-E14) in the National Health Insurance medical service claims data. NHSP, National Health Screening Program.